Frontlight ResearchEarly access
Trial site
Re:Cognition Health - London
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Migraine2 trials
- Mild cognitive impairment1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Pfizer2 trials
- Acumen Pharmaceuticals1 trial
- Alector Inc.1 trial
- Hoffmann-La Roche1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Migraine1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026